RS20110018A2 - Combined tablet form and procedures for production thereof - Google Patents

Combined tablet form and procedures for production thereof

Info

Publication number
RS20110018A2
RS20110018A2 RS20110018A RSP20110018A RS20110018A2 RS 20110018 A2 RS20110018 A2 RS 20110018A2 RS 20110018 A RS20110018 A RS 20110018A RS P20110018 A RSP20110018 A RS P20110018A RS 20110018 A2 RS20110018 A2 RS 20110018A2
Authority
RS
Serbia
Prior art keywords
production
procedures
total tablet
tablet form
tablet mass
Prior art date
Application number
RS20110018A
Other languages
Serbian (sr)
Inventor
Sonja GEĹ KOVSKA
Nataša ANEVSKA STOJANOVSKA
Efta Linin
Original Assignee
Alkaloid Ad-Skopje
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkaloid Ad-Skopje filed Critical Alkaloid Ad-Skopje
Publication of RS20110018A2 publication Critical patent/RS20110018A2/en
Publication of RS20110018A3 publication Critical patent/RS20110018A3/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Invention herewith described refers to the new form of combined tablets, containing four active components such as paracetamol from 35 to 45% w/w of the total tablet mass, propyphenazone from 25 to 37% w/w of the total tablet mass, codeine phosphate from 1.1 to 1.9% w/w of the total tablet mass and caffeine from 5 to 9% w/w of the total tablet mass as well as to the processes for the production thereof.
RS20110018A 2010-05-06 2011-01-13 Combined tablet form and procedures for production thereof RS20110018A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MK12310 2010-05-06

Publications (2)

Publication Number Publication Date
RS20110018A2 true RS20110018A2 (en) 2012-08-31
RS20110018A3 RS20110018A3 (en) 2013-04-30

Family

ID=46850298

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20110018A RS20110018A3 (en) 2010-05-06 2011-01-13 Combined tablet form and procedures for production thereof

Country Status (2)

Country Link
RS (1) RS20110018A3 (en)
RU (1) RU2578482C2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1287431A (en) * 1969-04-16 1972-08-31 Aspro Nicholas Ltd Improvements in pharmaceutical formulations
EP0272638B1 (en) * 1986-12-24 1992-05-20 F. Hoffmann-La Roche Ag Analgesic preparation
US4968509A (en) * 1987-07-27 1990-11-06 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
RU2191605C1 (en) * 2001-10-16 2002-10-27 Нестерук Владимир Викторович Analgetic, spasmolytic, anti-inflammatory agent
RU2220713C1 (en) * 2002-09-03 2004-01-10 Нестерук Владимир Викторович Analgetic, spasmolytic, anti-inflammatory medicinal agent
BG65692B1 (en) * 2003-06-19 2009-07-31 "Софарма" Ад Medicamentous form of combined preparation and method for the production thereof

Also Published As

Publication number Publication date
RU2578482C2 (en) 2016-03-27
RU2011101712A (en) 2012-07-27
RS20110018A3 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
TN2015000278A1 (en) Autotaxin inhibitors
PH12015500064B1 (en) Imidazotriazinecarbonitriles useful as kinase inhibitors
MY163083A (en) Solid forms of a pharmaceutically active substance
TN2013000348A1 (en) Compounds and compositions as trk inhibitors
MY189427A (en) Pyrazolyl quinoxaline kinase inhibitors
MX2011009369A (en) Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators.
MX339873B (en) Serine/threonine kinase inhibitors.
UA109661C2 (en) Pharmaceutical compositions comprising co-crystals of tramadol and celecoxib
MY161088A (en) Agonists of gpr40
WO2015019198A3 (en) High potency pancreatin pharmaceutical compositions
MX2013003309A (en) Substituted benzamide compounds.
WO2012174158A3 (en) Administration of benzodiazepine
MX2015004604A (en) Mglu2/3 antagonists for the treatment of autistic disorders.
MX340188B (en) Manufacturing of active-free granules and tablets comprising the same.
MX2011008825A (en) Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators.
MX2016000480A (en) High potency pancreatin pharmaceutical compositions.
NZ702253A (en) Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
TN2012000507A1 (en) Enteric tablet
MX363699B (en) Co-micronisation product comprising ulipristal acetate.
MX2011008662A (en) Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators.
MX2011009338A (en) Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators.
MX366829B (en) Itraconazole compositions and dosage forms, and methods of using the same.
MX2012002631A (en) Scented capsules.
RS20130034A1 (en) Pharmaceutical mixture for the prolonged release of trimetazidine